Nebojša Lalić
Serbian Academy of Sciences and Arts(RS)Serbian Academy of Sciences and Arts(RS)Diabetes Australia(AU)University of Belgrade(RS)Center for Health, Exercise and Sport Sciences(RS)Univerzitetski Klinički Centar Srbije(RS)Arheološki Institut(RS)University Clinical Centre(PL)Institut za Reumatologiju(RS)University of Arts in Belgrade(RS)
Publications by Year
Research Areas
Diabetes Management and Research, Diabetes Treatment and Management, Diabetes and associated disorders, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry(2019)911 cited
- → Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).(1997)890 cited
- → Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial(2009)827 cited
- → 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial(2017)824 cited
- → A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes(2010)477 cited
- → PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes